Long COVID drug study for adults 18 to 65
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This study tests whether a commonly used drug (repurposed) can help improve Long COVID symptoms like fatigue, breathing problems, or brain fog. It is for adults 18 to 65 who had COVID-19 in the past 4 years and still have symptoms after 3 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You had COVID-19 in the past 4 years (confirmed by a test or strong symptoms with exposure to a confirmed case).
- You have been diagnosed with Long COVID – symptoms that started or continued 3 months after your infection and lasted at least 2 months with no other explanation.
- You currently have at least one of these symptoms on most days: fatigue, trouble breathing, circulation issues, memory/thinking/communication problems, or muscle/joint pain.
- You are not pregnant, breastfeeding, or planning to become pregnant, and are willing to use birth control if needed.
- You are not taking certain supplements or medications, and you have not used JAK inhibitors before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the anti-inflammatory drug baricitinib can improve persistent long COVID symptoms like brain fog, fatigue, and shortness of breath. You may qualify if you had COVID-19 at least 6 months ago and still have bothersome symptoms that affect your daily life.
This trial tests if combining maraviroc and atorvastatin can help people with long COVID. You must have specific, persistent symptoms like brain fog, severe fatigue, or shortness of breath that started or got worse after a confirmed COVID-19 infection and have lasted over 6 months.
This trial tests a natural compound to see if it can reduce ongoing inflammation and symptoms like fatigue, brain fog, or shortness of breath that linger after a COVID-19 infection. It's for people who still have symptoms at least 2 months after getting sick.
This study tests whether medicines that fight viruses (similar to those used for herpes or COVID) can reduce Long COVID symptoms like fatigue and brain fog. Researchers believe lingering viruses or viral reactivation may drive Long COVID, and this trial will see if antiviral drugs help.
This trial tests if taking taurine, a natural amino acid supplement, can help reduce lingering symptoms of COVID-19 that last for months. If you have had COVID-19 and still have symptoms like fatigue or brain fog for at least 2 months after 3 months from your infection, this study might be for you.
This study tests whether antiviral drugs (Truvada and Selzentry) can help people with long COVID. You may qualify if you have had long COVID symptoms for at least 6 months, including fatigue and post-exertional malaise.
Hear when a new Long COVID trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.